+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer



Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer



American Journal of Obstetrics and Gynecology 196(4): E6-E9



We describe an unusual Ashkenazi Jewish patient with breast and epithelial ovarian cancer who was found to have simultaneous BRCA1 and BRCA2 mutations (BRCA1 5382insC and BRCA2 6174delT). While these mutations are known to occur individually in Ashkenazi Jewish women, concomitant BRCA1 and BRCA2 mutations in the same individual are rare.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 013668848

Download citation: RISBibTeXText

PMID: 17403394

DOI: 10.1016/j.ajog.2007.01.026


Related references

BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer. Genetic Testing 1(1): 41-46, 1997

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations. Gynecologic Oncology 121(2): 358-363, 2011

Prevalence of specific germline mutations in BRCA1 and BRCA2 in women affected with breast or ovarian cancer from the Ashkenazi Jewish population. Journal of Medical Genetics 34(SUPPL 1): S32, 1997

Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer. Journal of Medical Genetics 36(5): 369-373, 1999

Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Human Mutation 16(6): 491-501, 2000

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. Journal of the National Cancer Institute (Bethesda) 91(14): 1241-1247, July 21, 1999

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations. European Journal of Surgical Oncology 27(3): 278-281, 2001

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Clinical Cancer Research 8(12): 3776-3781, 2002

BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women. Annals of the New York Academy of Sciences 833: 198-203, 1998

High frequency of BRCA1 and BRCA2 mutations in Ashkenazi Jewish ovarian cancer patients. Gynecologic Oncology 70(1): 152, 1998

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiology, Biomarkers and Prevention 10(5): 467-473, 2001

Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. Cancer 118(2): 493-499, 2012

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature Medicine 2(11): 1179-1183, 1996